BUNKA CHRISTOPHER
Transaction: 03/17/2026
SELL
Change
-100,000
Price
Not reported
Filing
03/18/2026
Type
SELL
Lexaria Bioscience Corp.
LEXX • Biotechnology
Strong market move
LEXX+14.85%
vs. previous close $12.32
$14.15
▲ +1.83 (+14.85%)
Current price
EarningsLatest report: Feb 28, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$12.00M
Growth
-6.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.04Healthy liquidity · 2.32Negative growth trendWeak profitability
Financial data as of: Feb 28, 2026, 12:00 AM UTCLast earnings update: Apr 13, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$14.15
Change14.85%
Market Cap$12.00M
52W Range0.46 - 1.55
Beta0.34
Gross Margin99.61%
Oper. Margin-16.83%
Profit Margin-16.86%
Debt/Eq0.04
Current Ratio2.32
Quick Ratio2.32
Revenue 5Y-5.99%
Price$14.15
Change14.85%
Market Cap$12.00M
52W Range0.46 - 1.55
Beta0.34
Gross Margin99.61%
Oper. Margin-16.83%
Profit Margin-16.86%
Debt/Eq0.04
Current Ratio2.32
Quick Ratio2.32
Revenue 5Y-5.99%
Target$1.50
Target Upside-89.40%
Target Median$1.50
Target Range1.50 - 1.50
Volume50.64K
Avg Volume121.12K
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
32
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
40/100
Why this score▼
Manageable debt level · 0.04Healthy liquidity · 2.32Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-15
Low
$1.50
Mean
$1.50
Median
$1.50
High
$1.50
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
BUNKA CHRISTOPHER
Transaction: 07/30/2025
BUY
Change
+11,900
Price
$0.91
Filing
07/30/2025
Type
BUY
CHRISTOPHER RICHARD
Transaction: 07/29/2025
BUY
Change
+15,000
Price
$0.91
Filing
07/30/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| BUNKA CHRISTOPHER | SELL | -100,000 | Not reported | 03/17/2026 | 03/18/2026 |
| BUNKA CHRISTOPHER | BUY | +11,900 | $0.91 | 07/30/2025 | 07/30/2025 |
| CHRISTOPHER RICHARD | BUY | +15,000 | $0.91 | 07/29/2025 | 07/30/2025 |
| Carle Vanessa | BUY | +750 | $0.91 | 07/29/2025 | 07/30/2025 |
| DOCHERTY JOHN MARTIN | BUY | +5,376 | $0.93 | 07/29/2025 | 07/30/2025 |
| McKechnie William Edward | BUY | +5,000 | $0.91 | 07/29/2025 | 07/30/2025 |
| BUNKA CHRISTOPHER | BUY | +15,600 | $0.92 | 07/29/2025 | 07/30/2025 |
| REESE ALBERT L JR | BUY | +11,000 | $1.04 | 05/15/2025 | 05/16/2025 |
| Baxter Nicholas W | BUY | +11,000 | $1.04 | 05/15/2025 | 05/16/2025 |
| Bhullar Baljinder | BUY | +11,000 | $1.04 | 05/15/2025 | 05/16/2025 |
| Shankman Michael Elliot | BUY | +50,000 | $1.04 | 05/15/2025 | 05/16/2025 |
| DOCHERTY JOHN MARTIN | BUY | +150,000 | $1.04 | 05/15/2025 | 05/16/2025 |
| Carle Vanessa | BUY | +15,000 | $1.04 | 05/15/2025 | 05/16/2025 |
| BUNKA CHRISTOPHER | BUY | +11,000 | $1.04 | 05/15/2025 | 05/16/2025 |
| CHRISTOPHER RICHARD | BUY | +150,000 | $1.04 | 05/15/2025 | 05/16/2025 |
| Bhullar Baljinder | OTHER | 0 | Not reported | 01/14/2025 | 01/16/2025 |
| BUNKA CHRISTOPHER | BUY | +100,000 | Not reported | 01/07/2025 | 01/10/2025 |
| CHRISTOPHER RICHARD | BUY | +27,172 | $2.47 | 12/03/2024 | 12/03/2024 |
| CHRISTOPHER RICHARD | BUY | +22,828 | $2.24 | 12/02/2024 | 12/03/2024 |
| Shankman Michael Elliot | OTHER | +50,000 | $3.17 | 02/28/2025 | 10/02/2024 |